Skip to main content
Premium Trial:

Request an Annual Quote

Recent NIH Proteomics Awards in FY 2006*: Jan 26, 2006

Premium
Recent NIH Proteomics Awards in FY 2006*
Principal Investigator Institution
Award
Project Title
Bowser, Robert P University of Pittsburgh at Pittsburgh
$212,166
Proteomic profiling of CSF during SIV infection
Bukowski,
Radoslaw K
University of Texas Medical Branch Galveston
$188,750
Genomic/Proteomic Premature Birth Research Clinical Core
Cantor, Alan B Children's Hospital Boston
$355,935
Proteomic Study of Megakaryocyte Transcriptional Control
Dobrowsky, Rick T University of Kansas Lawrence
$346,987
Oxidative Stress and the Mitochondrial Proteome in Diabetic Neuropathy
Haggarty, Stephen J Massachusetts Institute of Technology
$153,900
Small-Molecule Probes for Conditional Modulation of the Synapse Proteome
Jaffrey, Samie R Weill Medical College of Cornell University
$210,000
Rapid ligand identification using HIV proteome microarrays
Jaffrey, Samie R Weill Medical College of Cornell University
$210,000
Proteome-wide identification of protease targets
Karger, Barry L Northeastern University
$482,637
Separation and Analytical Technologies for Proteomics
Khan, Saleem A University of Pittsburgh at Pittsburgh
$357,541
Genomic and Proteomic Analysis of HPV-Associated SCCHN
Link, Andrew J Vanderbilt University
$302,276
Proteomic analysis of eukaryotic protein synthesis
Liu, Rihe University of North Carolina Chapel Hill
$235,127
Identification of Caspase Substrates from Human Proteome
Mccarthy, James B University of Minnesota Twin Cities
$215,280
Melanoma Cell Surface Proteoglycans in Metastasis
Nilsson, Erik J Insilicos
$158,640
Heterogeneous Proteomics Data Analysis and Management
Pallanck, Leo J University of Washington
$174,938
Proteomic analyses of Drosophila Parkinson's disease model
Pickart, Cecile M Johns Hopkins University
$245,904
Proteolytic signaling by polyubiquitin chains
Power, Christopher T University of Alberta
$264,708
Neurotoxic Mechanisms Mediated By Lentivirus-Induced Proteolysis
Schnitzer, Jan E Sidney Kimmel Cancer Center
$639,812
Mapping Vascular Proteome for Organ Targeting In Vivo
Shannon, John M Children's Hospital Medical Center Cincinnati
$238,400
Chondroitin Sulfate Proteoglycans in Lung Development
Skoff, Robert P Wayne State University
$338,625
Processing and degradation of proteolipid protein
Solomon, Mark J Yale University
$373,750
Anaphase Promoting Complex-mediated Proteolysis
Sung, Uhna Vanderbilt University
$171,563
A Proteomic Analysis of the Norepinephrine Transporter
Wood, David O University of South Alabama
$292,000
Global Analysis of the Rickettsia prowazekii Proteome
Yates, John R Scripps Research Institute
$371,800
Proteomic Profiling of CFTR Protein Interaction
Yu, Xu Massachusetts General Hospital
$218,750
Functional Proteomics of HIV-1-Specific CD8+ T cells
Zhong, Guangming University of Texas Health Science Center San Antonio
$292,000
Chlamydia trachomatis proteomics

*Date compiled between Jan. 1, 2006 and Jan. 19, 2006.
SOURCE: NIH office of extramural research.
The site lists extramural awards in fiscal year 2006 by state/foreign site.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.